Podcast
Questions and Answers
What is the diagnosis of submassive PE based on?
What is the diagnosis of submassive PE based on?
What is the cutoff value for troponin I in diagnosing myocardial necrosis in PE?
What is the cutoff value for troponin I in diagnosing myocardial necrosis in PE?
Which of the following is a risk factor for VTE in hospitalized patients?
Which of the following is a risk factor for VTE in hospitalized patients?
What is the definition of low-risk PE?
What is the definition of low-risk PE?
Signup and view all the answers
What is the cutoff value for N-terminal pro-BNP in diagnosing RV dysfunction in PE?
What is the cutoff value for N-terminal pro-BNP in diagnosing RV dysfunction in PE?
Signup and view all the answers
Which of the following is a risk factor for VTE in surgical inpatients?
Which of the following is a risk factor for VTE in surgical inpatients?
Signup and view all the answers
What is the next step in diagnosis if a D-dimer test result is positive?
What is the next step in diagnosis if a D-dimer test result is positive?
Signup and view all the answers
What is McConnell's sign?
What is McConnell's sign?
Signup and view all the answers
What is the primary goal of risk stratification in patients with acute pulmonary embolism?
What is the primary goal of risk stratification in patients with acute pulmonary embolism?
Signup and view all the answers
What is hemodynamic instability in the context of pulmonary embolism?
What is hemodynamic instability in the context of pulmonary embolism?
Signup and view all the answers
What is the Hampton hump sign?
What is the Hampton hump sign?
Signup and view all the answers
What is the primary indication for performing a D-dimer test?
What is the primary indication for performing a D-dimer test?
Signup and view all the answers
What is the suggested treatment for patients with acute hypotensive PE with high bleeding risk or failed systemic thrombolysis?
What is the suggested treatment for patients with acute hypotensive PE with high bleeding risk or failed systemic thrombolysis?
Signup and view all the answers
What is the FDA-approved regimen for alteplase in high-risk PE?
What is the FDA-approved regimen for alteplase in high-risk PE?
Signup and view all the answers
Which of the following is an absolute contraindication to thrombolysis?
Which of the following is an absolute contraindication to thrombolysis?
Signup and view all the answers
What is the loading dose of streptokinase in FDA-approved regimen for PE?
What is the loading dose of streptokinase in FDA-approved regimen for PE?
Signup and view all the answers
Which of the following is a relative contraindication to thrombolysis?
Which of the following is a relative contraindication to thrombolysis?
Signup and view all the answers
What is the dose of urokinase in FDA-approved regimen for PE?
What is the dose of urokinase in FDA-approved regimen for PE?
Signup and view all the answers
Study Notes
D-Dimer Testing
- Not recommended if clinical suspicion is high, as a normal result does not exclude PE in patients with high predicted probability, even with high-sensitivity assays
- Positive result: perform diagnostic imaging
- Negative result: do not perform diagnostic imaging (PE may be excluded)
Diagnosis
- McConnell's sign: a distinct echocardiographic feature of acute massive PE, characterized by RV free wall akinesis with sparing of the apex
- Hampton hump sign: a dome-shaped area of opacification in the periphery of the left lower lobe, indicating PE
- CT angiogram: demonstrates multiple pulmonary artery filling defects, consistent with pulmonary emboli
Risk Stratification
- Assess all patients with acute PE for severity and risk of early death to determine management strategy
- Initially stratify patients by presence of hemodynamic instability to identify those at high risk of early death
- Hemodynamic instability definitions include:
- Cardiac arrest: need for CPR
- Obstructive shock: SBP < 90 mm Hg or vasopressors required to achieve blood pressure ≥ 90 mm Hg despite adequate filling status, with end-organ hypoperfusion
Management
- Catheter-directed thrombolysis: suggested in patients with acute hypotensive PE in case of high bleeding risk, failed systemic thrombolysis, and/or shock likely to result in death before systemic thrombolysis takes effect
- Surgical pulmonary embolectomy: suggested as an alternative to systemic thrombolysis if contraindicated or failed
High-Risk (Massive PE) Management
- Clot-specific lyrics and dosing regimens:
- Alteplase: 100 mg over 2 hours (FDA-approved)
- Urokinase: 4,400 units/kg over 10 minutes (FDA-approved)
- Streptokinase (no longer on market in US): 250,000 units loading dose over 30 minutes (FDA-approved)
- Absolute contraindications:
- Structural intracranial disease
- Previous intracranial hemorrhage
- Previous hemorrhagic stroke or stroke of unknown origin
- Ischemic stroke within 3 months
- Active bleeding or diathesis
- Recent intracranial or spinal surgery
- Recent lumbar puncture
- Major trauma, surgery, or head injury within 3 weeks
- Known malignant intracranial neoplasm
- Suspected aortic dissection
- Relative contraindications:
- Refractory HTN
- History of chronic, severe, and poorly controlled HTN
- Recent extracranial or internal bleeding
- Recent major surgery
- Recent invasive procedure
- Ischemic stroke > 3 months prior
- Current anticoagulation therapy
- Traumatic cardiopulmonary resuscitation
- Pericarditis or pericardial fluid
- Diabetic retinopathy
- Pregnancy
- Noncompressible vascular puncture site
- Dementia
- Age > 75 years old, low body weight, female, black race
- Active peptic ulcer, advanced hepatic disease, infective endocarditis
Submassive PE
- Defined as acute PE without systemic hypotension but with either RV dysfunction or myocardial necrosis
- RV dysfunction:
- RV dilation or RV systolic dysfunction on echocardiography
- Brain natriuretic peptide (BNP) > 90 pg/mL
- N-terminal pro-BNP > 500 pg/mL
- ECG changes
- Myocardial necrosis:
- Troponin I > 0.4 ng/mL or troponin T > 0.1 ng/mL
Low-Risk PE
- Defined as acute PE without clinical markers of adverse prognosis that define massive or submassive PE
Risk Factors
- In surgical inpatients:
- Pregnancy or postpartum
- Recent sepsis
- Malignancy
- Prior VTE
- Central venous access
- In hospitalized patients:
- Prior VTE
- Thrombophilia
- Surgery
- Cancer
- Pregnancy
- Immobilization
- Trauma
- Central venous access
- Medical illnesses:
- Cancer
- Prior VTE
- Inflammatory disease
- Infections
- Autoimmune disorders (IBD, SLE, and RA)
- Medications:
- Hormonal contraceptives
- Hormonal replacement therapy (HRT)
- Antipsychotics
- Fibrates
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
Identify the different categories of pulmonary embolism, including massive, submassive, and low-risk PE, and understand the clinical markers that define each category. Learn about the diagnosis and risk factors of PE.